Skip to main content
DNA Labs India

POLR3B Gene Leukodystrophy hypomyelinating type 8 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

POLR3B Gene Leukodystrophy hypomyelinating type 8 NGS Genetic Test

Short Name: POLR3B NGS Genetic Test

Also known as: Hypomyelinating Leukodystrophy Type 8 Genetic Test, POLR3B Gene Mutation Analysis, POLR3B-Related Leukodystrophy NGS Test

POLR3B Gene Leukodystrophy hypomyelinating type 8 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are generally delivered within 3 to 4 weeks after the laboratory receives the sample.. Free home collection in 300+ cities across India.

NGS Genetic TestAll ages; symptoms usually begin in infancy or early childhood🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect pathogenic and likely pathogenic variants in the POLR3B gene in patients with clinical or radiological features suggestive of hypomyelinating leukodystrophy type 8. Genetic confirmation supports the clinical diagnosis, aids in distinguishing this condition from other leukodystrophies, and provides a basis for family counselling, carrier testing, and reproductive planning.

Test Code
4197
CPT Code
N/A
ICD Code
N/A
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are generally delivered within 3 to 4 weeks after the laboratory receives the sample.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Fasting is not required. No special preparation is needed. Please carry any previous MRI reports, clinical records, or referral notes. A pre-test genetic counselling session is recommended to review the family history and obtain informed consent.

Method: Peripheral blood collection / FTA card blood spot submission

Step 2

Laboratory Analysis

A trained phlebotomist will collect a blood sample from a vein in the arm. If FTA card is used, one drop of blood will be placed on the marked circles. The procedure takes only a few minutes.

Step 3

Report Delivery

There are no activity restrictions after the blood draw. You can resume normal daily activities immediately. The sample will be sent to the laboratory for NGS analysis and reports will be delivered in 3 to 4 weeks.

Timeline: Reports are generally delivered within 3 to 4 weeks after the laboratory receives the sample.

Patient Instructions

1
Before the Test:Fasting is not required. A pre-test genetic counselling session should be completed to draw a family pedigree and discuss the benefits and limitations of the test.
2
During the Test:A blood sample is collected from a vein. The sample is processed in the laboratory and the POLR3B gene is enriched and sequenced using NGS technology.
3
After the Test:No restrictions. The laboratory will analyse the data and generate a clinical report. The treating doctor will explain the results and discuss next steps.

About This Test

Who Should Get This Test

The purpose of this test is to detect pathogenic and likely pathogenic variants in the POLR3B gene in patients with clinical or radiological features suggestive of hypomyelinating leukodystrophy type 8. Genetic confirmation supports the clinical diagnosis, aids in distinguishing this condition from other leukodystrophies, and provides a basis for family counselling, carrier testing, and reproductive planning.

How to Prepare

  • No fasting required
  • Prefer a doctor's referral if available
  • EDTA tube should be filled to the indicated mark
  • FTA card should be air-dried and placed in the provided pouch
  • Label the sample with the patient's name and date of birth

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test should be interpreted along with a detailed neurological assessment, MRI findings and family history. For at-risk couples, genetic counselling and targeted carrier testing are essential before and during pregnancy."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeNot specified in test details
ContainerEDTA blood collection tube, sterile DNA tube, or FTA card
Collection MethodPeripheral blood collection / FTA card blood spot submission

Sample Stability

Whole blood in EDTA: 24-48 hours at room temperature or 72 hours refrigerated
FTA card: stable at room temperature for several weeks
Extracted DNA: stable at -20 degree Celsius for long-term storage
Sample Rejection Criteria:
  • Hemolysed, clotted, or frozen whole blood
  • Insufficient sample quantity
  • Unlabeled or mislabeled specimen
  • Sample exposed to extreme heat
  • Sample container broken or leaking

Understanding Your Results

The result must be interpreted by a qualified clinical geneticist in the context of the patient's neurological examination, MRI findings, family history, and clinical presentation. It should not be used as a standalone screening test.
📊

Positive - pathogenic or likely pathogenic variant detected

Confirms the molecular diagnosis of hypomyelinating leukodystrophy type 8 associated with the POLR3B gene.

📊

Negative - no pathogenic variant detected

No clinically significant variant was identified in the POLR3B gene regions tested. It does not exclude all genetic causes of leukodystrophy.

📊

Variant of uncertain significance (VUS)

A variant was found but its role in disease is not yet clear. Additional family testing and segregation analysis may be helpful.

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if a child or adult shows developmental delay, loss of motor skills, abnormal muscle tone, coordination difficulty, seizures, vision or hearing impairment, or MRI evidence of hypomyelination.

Risks & Considerations

  • Minimal pain at the blood collection site
  • Small bruise or redness
  • Rare risk of local infection

Interfering Factors

  • Clotted or hemolyzed blood sample
  • Insufficient quantity of DNA
  • Contamination during sample collection
  • Recent allogeneic bone marrow transplant
  • Recent blood transfusion causing mixed DNA profile

Compare With Similar Tests

TestPOLR3B Gene Leukodystrophy hypomyelinating type 8 NGS Genetic Test
ComparisonPOLR3B Gene Leukodystrophy hypomyelinating type 8 NGS Genetic Test

Frequently Asked Questions

What is the cost of the POLR3B Gene Leukodystrophy Hypomyelinating Type 8 NGS Genetic Test?
The test costs Rs 20000 at DNA Labs India. It includes NGS analysis of the POLR3B gene, clinical interpretation, and raw data files (FASTQ and VCF) for transparency.
What sample type is accepted?
Blood, extracted DNA, or one drop of blood on an FTA card can be used. No fasting is required.
How long will the test take?
Reports are generally available in 3 to 4 weeks after the sample is received at the laboratory.
Why is this test done?
It is done to confirm a clinical diagnosis of hypomyelinating leukodystrophy type 8 caused by POLR3B gene variants, and to enable genetic counselling and family risk assessment.
What is hypomyelinating leukodystrophy type 8?
It is a rare inherited neurological disorder caused by pathogenic variants in the POLR3B gene. It affects myelin formation and leads to developmental delay, motor problems, seizures, and sometimes vision or hearing impairment.
Does the test detect all leukodystrophies?
No. This is a targeted NGS test that analyses the POLR3B gene only. If clinical suspicion remains after a negative result, a multi-gene leukodystrophy panel or whole exome sequencing may be advised.
Can this test be used for family planning?
Yes. Once a pathogenic POLR3B variant is identified in the family, targeted carrier testing and reproductive counselling can be arranged with the help of a clinical geneticist or obstetrician.
Should I have genetic counselling before the test?
Yes. Pre-test genetic counselling is recommended to draw a family pedigree, explain the benefits and limitations of the test, and obtain informed consent.
What does a positive result mean?
A pathogenic or likely pathogenic variant in POLR3B confirms the molecular diagnosis. Consultation with a clinical geneticist is advised for management and family testing.
What does a negative result mean?
A negative result means no clinically significant variants were found in the POLR3B gene regions tested. It does not completely exclude POLR3B-related disease if strong clinical and imaging findings are present.
Will I receive raw genetic data?
DNA Labs India shares raw data files, including FASTQ and VCF, along with the conclusive clinical report for this test.
Who should order this test?
A neurologist, pediatric neurologist, or clinical geneticist should order the test, ideally after clinical assessment, MRI findings, and genetic counselling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.